Craddock And Hyde Dental Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 125 W Harper St, Richland, MS 39218 Phone: 601-932-5100 |
Polk Dental Center Dentist Medicare: Not Enrolled in Medicare Practice Location: 120 Scarbrough St, Suite B, Richland, MS 39218 Phone: 601-932-0606 Fax: 601-932-0703 |
Dental Care Of Richland Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1055 Highway 49 S Ste C, Richland, MS 39218 Phone: 601-664-6655 Fax: 601-664-7224 |
Hilary Gaddis Craddock, Dmd, Pa Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 125 W Harper St, Richland, MS 39218 Phone: 601-932-5100 |
Craddock And Malley Dental Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 125 W Harper St, Richland, MS 39218 Phone: 601-932-5100 |
Dental Care Of Richland Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1055 Highway 49 S Ste C, Richland, MS 39218 Phone: 601-664-6655 |
News Archive
Republicans say the budget doesn't do enough to restrain entitlement spending. Health care industry groups, meanwhile, call proposed payment cuts unfair and unworkable.
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.
A transformative sector deal was announced between companies of the UK life sciences sector and the UK government on Wednesday, December 6th, 2017. This agreement draws substantial investment into the sector including the development of a trail-blazing digital pathology program leveraging Artificial Intelligence.
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) to acute myeloid leukemia. The finding could improve prognostication for patients with MDS and better inform therapeutic decision making.
› Verified 5 days ago